documents: FDA-2021-N-1343-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-1343-0001 | FDA | FDA-2021-N-1343 | Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Integrated Continuous Glucose Monitoring System | Rule | Final Rule | 2022-02-18T05:00:00Z | 2022 | 2 | 2022-02-18T05:00:00Z | 2022-02-18T14:23:19Z | 2022-03504 | 0 | 0 | 0900006484f85796 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref